Tatiana Ort is a prominent inventor based in Spring House, PA (US). She has made significant contributions to the field of immunology, holding a total of 7 patents. Her work focuses on the development of human antibodies that target CD27, a crucial component in immune response.

Latest Patents

Tatiana's latest patents include "Neutralizing human anti-CD27 antibodies" and "Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies." These patents describe human antibodies that can block the binding of CD27 to its ligand CD70. This action neutralizes the bioactivity of CD27, which is essential for T-cell proliferation, activation, and B-cell differentiation. The antibodies developed by Tatiana are valuable for diagnosing and treating diseases associated with CD27 activity.

Career Highlights

Tatiana Ort is currently employed at Janssen Biotech, Inc., where she continues her innovative work in immunology. Her research has the potential to impact various medical conditions related to immune response and cancer treatment.

Collaborations

Tatiana collaborates with notable colleagues, including John Wheeler and John Chen, who contribute to her research efforts and advancements in the field.

Conclusion

Tatiana Ort's contributions to immunology through her patents and work at Janssen Biotech, Inc. highlight her role as a leading inventor in the field. Her innovative approaches to targeting CD27 have the potential to transform treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.